Biotech Values

[DewDiligence]

Re: HCV impetus for GILD-KITE deal

Sure, GILD has been talking about a major acquisition for years, so why did GILD finally pull the M&A trigger now? Is it just a coincidence that GILD is just now facing the first bona fide threat to its HCV hegemony (Mavyret)?

GILD did not know until very recently—when seeing the FDA label and WAC price for Mavyret—how severe the threat was going to be.